| Year |
Citation |
Score |
| 2019 |
Syrett CM, Paneru B, Sandoval-Heglund D, Wang J, Banerjee S, Sindhava V, Behrens EM, Atchison M, Anguera MC. Altered X-chromosome inactivation in T cells may promote sex-biased autoimmune diseases. Jci Insight. 4. PMID 30944248 DOI: 10.1172/Jci.Insight.126751 |
0.314 |
|
| 2018 |
Syrett CM, Sindhava V, Sierra I, Dubin AH, Atchison M, Anguera MC. Diversity of Epigenetic Features of the Inactive X-Chromosome in NK Cells, Dendritic Cells, and Macrophages. Frontiers in Immunology. 9: 3087. PMID 30671059 DOI: 10.3389/Fimmu.2018.03087 |
0.314 |
|
| 2017 |
Syrett CM, Sindhava V, Hodawadekar S, Myles A, Liang G, Zhang Y, Nandi S, Cancro M, Atchison M, Anguera MC. Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells. Plos Genetics. 13: e1007050. PMID 28991910 DOI: 10.1371/Journal.Pgen.1007050 |
0.414 |
|
| 2016 |
Banerjee A, Sindhava V, Vuyyuru R, Jha V, Hodewadekar S, Manser T, Atchison ML. YY1 Is Required for Germinal Center B Cell Development. Plos One. 11: e0155311. PMID 27167731 DOI: 10.1371/Journal.Pone.0155311 |
0.351 |
|
| 2014 |
Atchison ML. Function of YY1 in Long-Distance DNA Interactions. Frontiers in Immunology. 5: 45. PMID 24575094 DOI: 10.3389/fimmu.2014.00045 |
0.342 |
|
| 2014 |
Basu A, Wilkinson FH, Colavita K, Fennelly C, Atchison ML. YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment. Nucleic Acids Research. 42: 2208-23. PMID 24285299 DOI: 10.1093/nar/gkt1187 |
0.362 |
|
| 2013 |
Pan X, Papasani M, Hao Y, Calamito M, Wei F, Quinn Iii WJ, Basu A, Wang J, Hodawadekar S, Zaprazna K, Liu H, Shi Y, Allman D, Cancro M, Atchison ML. YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus. The Embo Journal. 32: 1168-82. PMID 23531880 DOI: 10.1038/Emboj.2013.66 |
0.584 |
|
| 2012 |
Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML. Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. Plos One. 7: e30656. PMID 22292011 DOI: 10.1371/Journal.Pone.0030656 |
0.589 |
|
| 2012 |
Zaprazna K, Atchison ML. YY1 controls immunoglobulin class switch recombination and nuclear activation-induced deaminase levels. Molecular and Cellular Biology. 32: 1542-54. PMID 22290437 DOI: 10.1128/MCB.05989-11 |
0.383 |
|
| 2012 |
Hodawadekar S, Park K, Farrar MA, Atchison ML. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer. Journal of Immunology (Baltimore, Md. : 1950). 188: 2276-84. PMID 22279106 DOI: 10.4049/Jimmunol.1102239 |
0.378 |
|
| 2011 |
Atchison M, Basu A, Zaprazna K, Papasani M. Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects. Critical Reviews in Oncogenesis. 16: 143-61. PMID 22248052 DOI: 10.1615/CRITREVONCOG.V16.I3-4.20 |
0.332 |
|
| 2010 |
Basu A, Atchison ML. CtBP levels control intergenic transcripts, PHO/YY1 DNA binding, and PcG recruitment to DNA. Journal of Cellular Biochemistry. 110: 62-9. PMID 20082324 DOI: 10.1002/jcb.22487 |
0.335 |
|
| 2010 |
Basu A, Hodawadekar S, Andrews O, Knox A, Pan X, Wilkinson F, Atchison ML. YY1 PcG function as a Potential cancer Therapeutic Target Forum On Immunopathological Diseases and Therapeutics. 1: 31-50. DOI: 10.1615/Forumimmundisther.V1.I1-2.30 |
0.464 |
|
| 2009 |
Wei F, Zaprazna K, Wang J, Atchison ML. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Molecular and Cellular Biology. 29: 4612-22. PMID 19564417 DOI: 10.1128/MCB.00234-09 |
0.393 |
|
| 2007 |
Azim AC, Wang X, Park GY, Sadikot RT, Cao H, Mathew B, Atchison M, van Breemen RB, Joo M, Christman JW. NF-kappaB-inducing kinase regulates cyclooxygenase 2 gene expression in macrophages by phosphorylation of PU.1. Journal of Immunology (Baltimore, Md. : 1950). 179: 7868-75. PMID 18025233 DOI: 10.4049/Jimmunol.179.11.7868 |
0.38 |
|
| 2007 |
Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T, Monroe JG, Atchison ML, Thomas-Tikhonenko A. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. The Journal of Clinical Investigation. 117: 2602-10. PMID 17717600 DOI: 10.1172/Jci30842 |
0.33 |
|
| 2007 |
Wei F, Schöler HR, Atchison ML. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. The Journal of Biological Chemistry. 282: 21551-60. PMID 17525163 DOI: 10.1074/jbc.M611041200 |
0.35 |
|
| 2007 |
Hodawadekar S, Yu D, Cozma D, Freedman B, Sunyer O, Atchison ML, Thomas-Tikhonenko A. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages. Experimental Cell Research. 313: 331-40. PMID 17098231 DOI: 10.1016/J.Yexcr.2006.10.015 |
0.372 |
|
| 2006 |
Hodawadekar S, Wei F, Yu D, Thomas-Tikhonenko A, Atchison ML. Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential. Journal of Immunology (Baltimore, Md. : 1950). 177: 6165-71. PMID 17056545 DOI: 10.4049/Jimmunol.177.9.6165 |
0.357 |
|
| 2005 |
Bai Y, Srinivasan L, Perkins L, Atchison ML. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. Journal of Immunology (Baltimore, Md. : 1950). 175: 5160-9. PMID 16210620 DOI: 10.4049/JIMMUNOL.175.8.5160 |
0.353 |
|
| 2005 |
Srinivasan L, Pan X, Atchison ML. Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue. Journal of Cellular Biochemistry. 96: 689-99. PMID 16052488 DOI: 10.1002/Jcb.20562 |
0.553 |
|
| 2005 |
McDevit DC, Perkins L, Atchison ML, Nikolajczyk BS. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association. Journal of Immunology (Baltimore, Md. : 1950). 174: 2834-42. PMID 15728493 DOI: 10.4049/Jimmunol.174.5.2834 |
0.369 |
|
| 2004 |
Boopathi E, Lenka N, Prabu SK, Fang JK, Wilkinson F, Atchison M, Giallongo A, Avadhani NG. Regulation of murine cytochrome c oxidase Vb gene expression during myogenesis: YY-1 and heterogeneous nuclear ribonucleoprotein D-like protein (JKTBP1) reciprocally regulate transcription activity by physical interaction with the BERF-1/ZBP-89 factor. The Journal of Biological Chemistry. 279: 35242-54. PMID 15190078 DOI: 10.1074/Jbc.M403160200 |
0.433 |
|
| 2003 |
Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. Transcription factor YY1 functions as a PcG protein in vivo. The Embo Journal. 22: 1347-58. PMID 12628927 DOI: 10.1093/emboj/cdg124 |
0.348 |
|
| 2003 |
Yu D, Allman D, Goldschmidt MH, Atchison ML, Monroe JG, Thomas-Tikhonenko A. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood. 101: 1950-5. PMID 12406913 DOI: 10.1182/Blood-2002-06-1797 |
0.364 |
|
| 2002 |
Nagulapalli S, Goheer A, Pitt L, McIntosh LP, Atchison ML. Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts. Molecular and Cellular Biology. 22: 7337-50. PMID 12242308 DOI: 10.1128/Mcb.22.20.7337-7350.2002 |
0.364 |
|
| 2002 |
Hong W, Kim AY, Ky S, Rakowski C, Seo SB, Chakravarti D, Atchison M, Blobel GA. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1 Molecular and Cellular Biology. 22: 3729-3743. PMID 11997509 DOI: 10.1128/Mcb.22.11.3729-3743.2002 |
0.409 |
|
| 2000 |
Maitra S, Atchison M. BSAP can repress enhancer activity by targeting PU.1 function. Molecular and Cellular Biology. 20: 1911-22. PMID 10688639 DOI: 10.1128/Mcb.20.6.1911-1922.2000 |
0.623 |
|
| 1998 |
Nagulapalli S, Atchison ML. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Molecular and Cellular Biology. 18: 4639-50. PMID 9671474 DOI: 10.1128/MCB.18.8.4639 |
0.314 |
|
| 1998 |
Fisher RC, Olson MC, Pongubala JMR, Perkel JM, Atchison ML, Scott EW, Simon MC. Normal myeloid development requires both the glutaminerich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain Molecular and Cellular Biology. 18: 4347-4357. PMID 9632818 DOI: 10.1128/Mcb.18.7.4347 |
0.307 |
|
| 1997 |
Zhang C, Gadue P, Scott E, Atchison M, Poncz M. Activation of the megakaryocyte-specific gene platelet basic protein (PBP) by the Ets family factor PU.1. The Journal of Biological Chemistry. 272: 26236-46. PMID 9334192 DOI: 10.1074/Jbc.272.42.26236 |
0.437 |
|
| 1997 |
Pongubala JM, Atchison ML. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proceedings of the National Academy of Sciences of the United States of America. 94: 127-32. PMID 8990172 DOI: 10.1073/pnas.94.1.127 |
0.312 |
|
| 1995 |
Pongubala JM, Atchison ML. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer. The Journal of Biological Chemistry. 270: 10304-13. PMID 7730336 DOI: 10.1074/jbc.270.17.10304 |
0.318 |
|
| 1993 |
Pongubala JMR, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation Science. 259: 1622-1625. PMID 8456286 DOI: 10.1126/Science.8456286 |
0.371 |
|
| 1993 |
Satyamoorthy K, Park K, Atchison ML, Howe CC. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements. Molecular and Cellular Biology. 13: 6621-8. PMID 8413258 DOI: 10.1128/MCB.13.11.6621 |
0.3 |
|
| 1992 |
Pongubala JMR, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity Molecular and Cellular Biology. 12: 368-378. PMID 1729611 |
0.312 |
|
| 1991 |
Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proceedings of the National Academy of Sciences of the United States of America. 88: 9804-8. PMID 1946405 DOI: 10.1073/pnas.88.21.9804 |
0.302 |
|
| 1991 |
Pongubala JM, Atchison ML. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Molecular and Cellular Biology. 11: 1040-7. PMID 1899281 DOI: 10.1128/MCB.11.2.1040 |
0.384 |
|
| 1989 |
Atchison ML, Meyuhas O, Perry RP. Localization of transcriptional regulatory elements and nuclear factor binding sites in mouse ribosomal protein gene rpL32. Molecular and Cellular Biology. 9: 2067-74. PMID 2546059 DOI: 10.1128/MCB.9.5.2067 |
0.322 |
|
| 1988 |
Kelley DE, Pollok BA, Atchison ML, Perry RP. The coupling between enhancer activity and hypomethylation of kappa immunoglobulin genes is developmentally regulated. Molecular and Cellular Biology. 8: 930-7. PMID 3127693 DOI: 10.1128/MCB.8.2.930 |
0.363 |
|
| 1987 |
Atchison ML, Perry RP. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cell. 48: 121-8. PMID 3098435 DOI: 10.1016/0092-8674(87)90362-X |
0.367 |
|
| 1986 |
Atchison M, Adesnik M. Gene conversion in a cytochrome P-450 gene family Proceedings of the National Academy of Sciences of the United States of America. 83: 2300-2304. PMID 3458196 DOI: 10.1073/Pnas.83.8.2300 |
0.331 |
|
| 1986 |
Atchison ML, Perry RP. Tandem kappa immunoglobulin promoters are equally active in the presence of the kappa enhancer: implications for models of enhancer function. Cell. 46: 253-62. PMID 3087628 DOI: 10.1016/0092-8674(86)90742-7 |
0.31 |
|
| Show low-probability matches. |